The AOD9604 Pen delivers a convenient ready-to-use format of a modified peptide fragment derived from human growth hormone (HGH). AOD9604 has been extensively studied for its potential role in supporting fat metabolism while avoiding many of the broader physiological effects associated with growth hormone itself, making it an area of interest within metabolic medicine and body composition optimisation. Frequently incorporated into clinic-led weight management and longevity programmes, AOD9604 is utilised as part of comprehensive treatment plans that combine personalised nutrition, exercise, and lifestyle interventions. Its targeted approach has made it a popular option for practitioners seeking advanced metabolic support within medically supervised wellness programmes. The ready-to-use injectable pen provides simplified administration, consistent dosing, and an enhanced patient experience, eliminating the need for peptide reconstitution while delivering premium clinical convenience.

Supports healthy fat metabolism Assists advanced body composition programmes Supports metabolic health and wellness optimisation Designed for clinic-led weight management protocols Complements nutrition and lifestyle interventions Ready-to-use injectable pen with consistent dosing Eliminates the need for peptide reconstitution

Sign in with an approved clinic account to access product documentation.